Volume 14(1); 2024 Mar

Hypothesis & Experience

Accessibility to plasma-derived medicinal products in Malaysia: The challenges faced by patients with inborn errors of immunity

Bruce Wee Diong Lim, Amir Hamzah Abdul Latiff

Asia Pac Allergy. 2024 Mar; 14(1): 1–4. Published online 2024 Feb 6. doi: 10.5415/apallergy.0000000000000136

PMCID:: PMC10932482

Article PDF–281K

Original Study

A prospective observational study correlating possible novel biomarkers with disease severity and antihistamine response in chronic spontaneous urticaria

Divya Bhatia, Hitaishi Mehta, Anuradha Bishnoi, Niharika Srivastava, Keshavamurthy Vinay, Davinder Parsad, Muthu Sendhil Kumaran

Asia Pac Allergy. 2024 Mar; 14(1): 5–11. Published online 2024 Jan 11. doi: 10.5415/apallergy.0000000000000132

PMCID:: PMC10932479

Article PDF–688K

Correlation of Blomia tropicalis-specific immunoglobulin epsilon profiles with family history of atopy in a Filipino population

Chanie Y. Patanindagat, Jamie Ezra B. Tarun, Ryla Jasmine T. Pajaro, Jhon Jerald D. Pintucan, Patricia Nichole M. Quilang, Maureen B. Sabit, John Donnie A. Ramos

Asia Pac Allergy. 2024 Mar; 14(1): 12–20. Published online 2024 Jan 11. doi: 10.5415/apallergy.0000000000000133

PMCID:: PMC10932478

Article PDF–619K

Prevalence of allergic sensitization to Platanus occidentalis among adults with allergic rhinitis: A multicenter study

Martín Bedolla-Barajas, Javier Domínguez-Morales, Ilse Mariana Loya-Barriga, Angie Bedolla-Pulido, Luis Alfredo Jiménez-Huerta, Jaime Morales-Romero

Asia Pac Allergy. 2024 Mar; 14(1): 21–25. Published online 2023 Dec 18. doi: 10.5415/apallergy.0000000000000127

PMCID:: PMC10932483

Article PDF–588K

Anti-thymic stromal lymphopoietin monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps (DUBHE): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled study

Shen Shen, Mu Xian, Bing Yan, Feng Lan, Chengshuo Wang, Luo Zhang

Asia Pac Allergy. 2024 Mar; 14(1): 26–31. Published online 2024 Jan 25. doi: 10.5415/apallergy.0000000000000135

PMCID:: PMC10932481

Article PDF–421K

Review Article

Biomarkers in allergen immunotherapy: Focus on eosinophilic inflammation

Chang-Keun Kim, Zak Callaway, Jin-Sung Park, Ruby Pawankar, Takao Fujisawa

Asia Pac Allergy. 2024 Mar; 14(1): 32–38. Published online 2023 Dec 18. doi: 10.5415/apallergy.0000000000000129

PMCID:: PMC10932480

Article PDF–344K

Case Report

The treatment efficacy of dupilumab in autosomal dominant hyper-immunoglobulin E syndrome with severe atopic dermatitis

Weifeng Li, Qiqi Qi, Weipeng Wang, Dongqin Li

Asia Pac Allergy. 2024 Mar; 14(1): 39–41. Published online 2023 Oct 9. doi: 10.5415/apallergy.0000000000000121

PMCID:: PMC10932477

Article PDF–390K

Letter to the Editor

Does omalizumab increase the risk of malignancy? A retrospective case-control study in a single tertiary hospital

Hyun Jee Kim, Suh Young Lee, Sang-Heon Cho, Hye-Ryun Kang

Asia Pac Allergy. 2024 Mar; 14(1): 42–43. Published online 2024 Mar 5. doi: 10.5415/apallergy.0000000000000137

PMCID:: PMC10932485

Article PDF–274K

Articles from Asia Pacific Allergy are provided here courtesy of Asia Pacific Association of Allergy, Asthma and Clinical Immunology